Source:http://linkedlifedata.com/resource/pubmed/id/21388427
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-7-6
|
pubmed:abstractText |
The aim of this investigation was to examine the role of perforin (P)-mediated cytotoxicity in the dynamics of tissue damage in patients with non-ST-segment elevation myocardial infarction (NSTEMI) treated with anti-ischaemic drugs. We enrolled 48 patients with NSTEMI in this study [age, 71.5 years; 61.5/76 (median, 25th/75th percentiles)]. The percentage of total peripheral blood P(+) lymphocytes was elevated owing to the increased frequency of P(+) cells within natural killer (NK) subsets, T and NKT cells in patients on day 1 after NSTEMI when compared with healthy controls. Positive correlations were found between cardiac troponin I plasma concentrations and the frequency of P(+) cells, P(+) T cells, P(+) NK cells and their CD56(+dim) and CD56(+bright) subsets during the first week after the NSTEMI. The expression of P in NK cells was accompanied by P-mediated cytotoxicity against K-562 targets at all days examined, except day 21, when an anti-perforin monoclonal antibody did not completely abolish the killing. The percentage of P(+) T cells, P(+) NKT cells and P(+) NK subsets was the highest on the day 1 after NSTEMI and decreased in the post-infarction period. CD56(+) lymphocytes were found in damaged myocardium, suggesting their tissue recruitment. In conclusion, patients with NSTEMI have a strong and prolonged P-mediated systemic inflammatory reaction, which may sustain autoaggressive reactions towards myocardial tissue during the development of myocardial infarction.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1365-3083
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-204
|
pubmed:meshHeading |
pubmed-meshheading:21388427-Aged,
pubmed-meshheading:21388427-Antigens, CD56,
pubmed-meshheading:21388427-Autoimmunity,
pubmed-meshheading:21388427-Cytotoxicity, Immunologic,
pubmed-meshheading:21388427-Electrocardiography,
pubmed-meshheading:21388427-Female,
pubmed-meshheading:21388427-Humans,
pubmed-meshheading:21388427-K562 Cells,
pubmed-meshheading:21388427-Killer Cells, Natural,
pubmed-meshheading:21388427-Male,
pubmed-meshheading:21388427-Middle Aged,
pubmed-meshheading:21388427-Myocardial Infarction,
pubmed-meshheading:21388427-Natural Killer T-Cells,
pubmed-meshheading:21388427-Perforin,
pubmed-meshheading:21388427-Troponin I
|
pubmed:year |
2011
|
pubmed:articleTitle |
Perforin-mediated cytotoxicity in non-ST elevation myocardial infarction.
|
pubmed:affiliation |
Division of Cardiology, Hospital for Medical Rehabilitation of Hearth and Lung Diseases and Rheumatism Thalassotherapia-Opatija, Opatija, Croatia. Gordana.Laskarin@medri.hr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|